Literature DB >> 29465685

Ciprofloxacin May be Efficacious in Treating Wild-Type Gyrase A Genotype Neisseria gonorrhoeae Infections.

Lao-Tzu Allan-Blitz1, Peera Hemarajata, Romney M Humphries, Mabel Kimble, Sam Elias, Jeffrey D Klausner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29465685      PMCID： PMC5847432          DOI： 10.1097/OLQ.0000000000000758

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


× No keyword cloud information.
  10 in total

Review 1.  Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis.

Authors:  Lao-Tzu Allan-Blitz; Xiaoyan Wang; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2017-05       Impact factor: 2.830

2.  An Illustration of the Potential Health and Economic Benefits of Combating Antibiotic-Resistant Gonorrhea.

Authors:  Harrell W Chesson; Robert D Kirkcaldy; Thomas L Gift; Kwame Owusu-Edusei; Hillard S Weinstock
Journal:  Sex Transm Dis       Date:  2018-04       Impact factor: 2.830

Review 3.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors:  Magnus Unemo; Robert A Nicholas
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

4.  A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection.

Authors:  Lao-Tzu Allan-Blitz; Peera Hemarajata; Romney M Humphries; Adriane Wynn; Eddy R Segura; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2018-02       Impact factor: 2.830

5.  Implementation of a Rapid Genotypic Assay to Promote Targeted Ciprofloxacin Therapy of Neisseria gonorrhoeae in a Large Health System.

Authors:  Lao-Tzu Allan-Blitz; Romney M Humphries; Peera Hemarajata; Ashima Bhatti; Mark W Pandori; Mark J Siedner; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

6.  Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: a worldwide summary.

Authors:  R M Echols; A Heyd; B J O'Keeffe; P Schacht
Journal:  Sex Transm Dis       Date:  1994 Nov-Dec       Impact factor: 2.830

Review 7.  Molecular tests for the detection of antimicrobial resistant Neisseria gonorrhoeae: when, where, and how to use?

Authors:  Nicola Low; Magnus Unemo
Journal:  Curr Opin Infect Dis       Date:  2016-02       Impact factor: 4.915

8.  Performance and Verification of a Real-Time PCR Assay Targeting the gyrA Gene for Prediction of Ciprofloxacin Resistance in Neisseria gonorrhoeae.

Authors:  P Hemarajata; S Yang; O O Soge; R M Humphries; J D Klausner
Journal:  J Clin Microbiol       Date:  2016-01-06       Impact factor: 5.948

9.  Antibiotic-Resistant Neisseria gonorrhoeae Spread Faster with More Treatment, Not More Sexual Partners.

Authors:  Stephanie M Fingerhuth; Sebastian Bonhoeffer; Nicola Low; Christian L Althaus
Journal:  PLoS Pathog       Date:  2016-05-19       Impact factor: 6.823

10.  Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea.

Authors:  Ashleigh R Tuite; Thomas L Gift; Harrell W Chesson; Katherine Hsu; Joshua A Salomon; Yonatan H Grad
Journal:  J Infect Dis       Date:  2017-11-27       Impact factor: 5.226
  10 in total
  6 in total

1.  Point-by-Point Progress: Gonorrhea Point of Care Tests.

Authors:  Charlotte A Gaydos; Johan H Melendez
Journal:  Expert Rev Mol Diagn       Date:  2020-06-30       Impact factor: 5.225

2.  A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility.

Authors:  Alexander Y Trick; Johan H Melendez; Fan-En Chen; Liben Chen; Annet Onzia; Aidah Zawedde; Edith Nakku-Joloba; Peter Kyambadde; Emmanuel Mande; Joshua Matovu; Maxine Atuheirwe; Richard Kwizera; Elizabeth A Gilliams; Yu-Hsiang Hsieh; Charlotte A Gaydos; Yukari C Manabe; Matthew M Hamill; Tza-Huei Wang
Journal:  Sci Transl Med       Date:  2021-05-12       Impact factor: 17.956

3.  Antimicrobial Susceptibility of Neisseria gonorrhoeae Isolates in Baltimore, Maryland, 2016: The Importance of Sentinel Surveillance in the Era of Multi-Drug-Resistant Gonorrhea.

Authors:  Johan H Melendez; Justin Hardick; Mathilda Barnes; Kathleen R Page; Charlotte A Gaydos
Journal:  Antibiotics (Basel)       Date:  2018-08-17

4.  Genotypic and Phenotypic Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae: a Cross-Sectional Study of Isolates Recovered from Routine Urine Cultures in a High-Incidence Setting.

Authors:  Adam L Bailey; Robert F Potter; Meghan A Wallace; Caitlin Johnson; Gautam Dantas; C A Burnham
Journal:  mSphere       Date:  2019-07-24       Impact factor: 4.389

5.  Can Ciprofloxacin be Used for Precision Treatment of Gonorrhea in Public STD Clinics? Assessment of Ciprofloxacin Susceptibility and an Opportunity for Point-of-Care Testing.

Authors:  Johan H Melendez; Yu-Hsiang Hsieh; Mathilda Barnes; Justin Hardick; Elizabeth A Gilliams; Charlotte A Gaydos
Journal:  Pathogens       Date:  2019-10-14

6.  Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.

Authors:  Jeffrey D Klausner; Claire C Bristow; Olusegun O Soge; Akbar Shahkolahi; Toni Waymer; Robert K Bolan; Susan S Philip; Lenore E Asbel; Stephanie N Taylor; Leandro A Mena; Deborah A Goldstein; Jonathan A Powell; Michael R Wierzbicki; Sheldon R Morris
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.